What's breaking now, across thousands of outlets.
Stress, sleep disorders, lack of energy, digestive problems or joint pain... Every excuse is good to take capsules, drops, or tablets. This market has tripled in fifteen years to reach 3 billion euros in turnover in France, attracting a few large groups and a host of start-ups.
We haven't written up this one. Le Monde Economie has the full story — the link below goes straight to it.
Korean biopharmaceutical group HLB is getting a second shot at U.S. Food and Drug Administration (FDA) approval for its flagship liver cancer therapy.
The hospital cannot turn them away as it does not have a 'wrong-door' policy, says state executive councillor Daniel Gooi.
The hospital cannot turn them away as it does not have a 'wrong-door' policy, says state executive councillor Daniel Gooi.
Scientists have developed a promising new cancer-fighting strategy that uses carbon monoxide naturally produced by tumor cells to manufacture powerful drugs inside the cancer cells themselves.
Scientists have developed a promising new cancer-fighting strategy that uses carbon monoxide naturally produced by tumor cells to manufacture powerful drugs inside the cancer cells themselves.
KUALA LUMPUR, Nov 4 (Bernama) -- AGC Biologics has expanded its existing long-term manufacturing agreement with a global pharmaceutical company to include its Copenhagen facility, lifting the deal’s…
